In 2021, the FDA approved two groundbreaking medications—Semaglutide and Tirzepatide—for chronic weight management in adults who are obese or overweight. These injections are being hailed as transformative treatments that could significantly change the landscape of obesity management. The Shift in Perception of Obesity Historically, obesity